Abstract
Purpose
To show that an immediate vitrectomy with an intravitreal injection of antibiotics can be an effective approach for the treatment of acute endophthalmitis following intravitreal injections.
Methods
We reviewed all cases of clinical endophthalmitis caused by an intravitreal injection that were treated in our department between March 2012 and November 2019. Only patients that underwent a vitrectomy within 6 h after presentation to the clinic and with a documented visual acuity shortly before the causative event were included. Baseline best-corrected visual acuity (BCVA) before the causative event was compared to BCVA measured within a follow-up period of 8 months (up to 14 months).
Results
In total, 30 eyes of 30 patients were included. The BCVA before the intraocular infection was a mean value of 0.55 logMAR, and the BCVA on the day of the endophthalmitis decreased significantly to 1.66 logMAR. Within 2 months following the pars plana vitrectomy (PPV), the mean BCVA improved to 0.83 logMAR. Eight months following PPV (mean value, 8.20 months; SD, 3.59 months), the mean BCVA was 0.63 logMAR. In the last follow-up interval most of the eyes recovered, and the BCVA did not differ significantly from baseline. Two eyes underwent further pars plana surgery during the follow-up period. No enucleation was required.
Conclusion
In this study, we have shown that an immediate vitrectomy with subsequent intravitreal injection of antibiotics is an effective option for treating post-injection endophthalmitis and frequently results in recovery of vision; thus, it should be performed as early as possible, where available.
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00417-021-05071-w/MediaObjects/417_2021_5071_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-021-05071-w/MediaObjects/417_2021_5071_Fig1_HTML.png)
Similar content being viewed by others
Change history
18 October 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00417-021-05179-z
References
Forooghian F, Albiani DA, Kirker AW, Merkur AB (2017) Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept. Can J Ophthalmol 52:616–619. https://doi.org/10.1016/j.jcjo.2017.04.016
Garg P, Roy A, Sharma S (2017) Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol 28:67–72. https://doi.org/10.1097/ICU.0000000000000326
Gower EW, Keay LJ, Stare DE, Arora P, Cassard SD, Behrens A, Tielsch JM, Schein OD (2015) Characteristics of Endophthalmitis after cataract surgery in the United States Medicare population. Ophthalmology 122:1625–1632. https://doi.org/10.1016/j.ophtha.2015.04.036
Czajka MP, Byhr E, Olivestedt G, Olofsson EM (2016) Endophthalmitis after small-gauge vitrectomy: a retrospective case series from Sweden. Acta Ophthalmol 94:829–835. https://doi.org/10.1111/aos.13121
Bhende M, Raman R, Jain M, Shah PK, Sharma T, Gopal L, Bhende PS, Srinivasan S, Jambulingam M, Sankara Nethralaya Vitreoretinal Study G (2018) Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital. PLoS One 13:e0191173. https://doi.org/10.1371/journal.pone.0191173
Cohen SM, Flynn HW Jr, Murray TG, Smiddy WE (1995) Endophthalmitis after pars plana vitrectomy. The Postvitrectomy Endophthalmitis Study Group. Ophthalmology 102:705–712. https://doi.org/10.1016/s0161-6420(95)30965-7
Zheng CX, Moster MR, Khan MA, Chiang A, Garg SJ, Dai Y, Waisbourd M (2017) Infectious endophthalmitis after glaucoma drainage implant surgery: clinical features, microbial spectrum, and outcomes. Retina 37:1160–1167. https://doi.org/10.1097/IAE.0000000000001329
Solborg Bjerrum S, Prause JU, Fuchs J, la Cour M, Kiilgaard JF (2016) Morphological features in eyes with endophthalmitis after cataract surgery - histopathology and optical coherence tomography assessment. Acta Ophthalmol 94:26–30. https://doi.org/10.1111/aos.12858
Damm LJ, Boden KT, Januschowski K (2019) Stellenwert der Vitrektomie bei Endophthalmitis: Wie eine prompte Vitrektomie den Visus wiederherstellen kann. Ophthalmologe 116:569–571. https://doi.org/10.1007/s00347-018-0768-z
Ho IV, Fernandez-Sanz G, Levasseur S, Ting E, Liew G, Playfair J, Downie J, Gorbatov M, Hunyor AP, Chang AA (2019) Early pars plana vitrectomy for treatment of acute infective Endophthalmitis. Asia Pac J Ophthalmol (Phila) 8:3–7. https://doi.org/10.22608/APO.2018414
Group EVS (1995) Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113:1479–1496. https://doi.org/10.1001/archopht.1995.01100120009001
Al Mahmood AM, Al-Swailem SA, Behrens A (2014) Clear corneal incision in cataract surgery. Middle East Afr J Ophthalmol 21:25–31. https://doi.org/10.4103/0974-9233.124084
Kasi SK, Hariprasad SM, Hsu J (2017) Making the jump to 27-gauge vitrectomy: perspectives. Ophthalmic Surg Lasers Imaging Retin 48:450–456. https://doi.org/10.3928/23258160-20170601-02
Wong TY, Chee SP (2004) Risk factors of acute endophthalmitis after cataract extraction: a case-control study in Asian eyes. Br J Ophthalmol 88:29–31. https://doi.org/10.1136/bjo.88.1.29
Boisgontier MP, Cheval B (2016) The ANOVA to mixed model transition. Neurosci Biobehav Rev 68:1004–1005. https://doi.org/10.1016/j.neubiorev.2016.05.034
Casals M, Girabent-Farres M, Carrasco JL (2014) Methodological quality and reporting of generalized linear mixed models in clinical medicine (2000-2012): a systematic review. PLoS One 9:e112653. https://doi.org/10.1371/journal.pone.0112653
Detry MA, Ma Y (2016) Analyzing repeated measurements using mixed models. JAMA 315:407–408. https://doi.org/10.1001/jama.2015.19394
McGlothlin AE, Viele K (2018) Bayesian hierarchical models. JAMA 320:2365–2366. https://doi.org/10.1001/jama.2018.17977
Inoue M, Kobayakawa S, Sotozono C, Komori H, Tanaka K, Suda Y, Matsushima H, Kinoshita S, Senoo T, Tochikubo T, Kadonosono K (2011) Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmologica 226:145–150. https://doi.org/10.1159/000329863
Garg SJ, Dollin M, Hsu J, Storey P, Vander JF (2015) Effect of a strict ‘no-talking’ policy during intravitreal injection on post-injection endophthalmitis. Ophthalmic Surg Lasers Imaging Retin 46:1028–1034. https://doi.org/10.3928/23258160-20151027-07
McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 31:654–661. https://doi.org/10.1097/IAE.0b013e31820a67e4
Levinson JD, Garfinkel RA, Berinstein DM, Flory M, Spellman FA (2018) Timing of povidone-iodine application to reduce the risk of endophthalmitis after intravitreal injections. Ophthalmol Retin 2:654–658. https://doi.org/10.1016/j.oret.2017.06.004
Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, Albini TA, Lalwani GA, Kovach JL, Puliafito CA (2011) Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 31:662–668. https://doi.org/10.1097/IAE.0b013e31821067c4
Lyall DA, Tey A, Foot B, Roxburgh ST, Virdi M, Robertson C, MacEwen CJ (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 26:1517–1526. https://doi.org/10.1038/eye.2012.199
Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA (2013) Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection. Retina 33:1407–1416. https://doi.org/10.1097/IAE.0b013e3182807659
Ng JQ, Morlet N, Pearman JW, Constable IJ, McAllister IL, Kennedy CJ, Isaacs T, Semmens JB, Team E (2005) Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the Endophthalmitis Population Study of Western Australia (EPSWA)’s fifth report. Ophthalmology 112:1199–1206. https://doi.org/10.1016/j.ophtha.2005.01.050
Kuhn FGG (2007) Complete and early vitrectomy for endophthalmitis vitreo-retinal surgery (part of the essentials in ophthalmology book series (ESSENTIALS)), p 16
Yospaiboon Y, Meethongkam K, Sinawat S, Laovirojjanakul W, Ratanapakorn T, Sanguansak T, Bhoomibunchoo C (2018) Predictive factors in the treatment of streptococcal endophthalmitis. Clin Ophthalmol 12:859–864. https://doi.org/10.2147/OPTH.S161217
Durand ML (2013) Endophthalmitis. Clin Microbiol Infect 19:227–234. https://doi.org/10.1111/1469-0691.12118
Barry P, Cordovés L; Gardner, S (2013) ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery data, Dilemmas and Conclusions. ESCRS
Pflugfelder SC, Hernandez E, Fliesler SJ, Alvarez J, Pflugfelder ME, Forster RK (1987) Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. Arch Ophthalmol 105:831–837. https://doi.org/10.1001/archopht.1987.01060060117045
Grzybowski A, Turczynowska M, Kuhn F (2018) The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? Acta Ophthalmol 96:e651–e654. https://doi.org/10.1111/aos.13623
Ching Wen Ho D, Agarwal A, Lee CS, Chhablani J, Gupta V, Khatri M, Nirmal J, Pavesio C, Agrawal R (2018) A review of the role of intravitreal corticosteroids as an adjuvant to antibiotics in infectious endophthalmitis. Ocul Immunol Inflamm 26:461–468. https://doi.org/10.1080/09273948.2016.1245758
Manning S, Ugahary LC, Lindstedt EW, Wubbels RJ, van Dissel JT, Jansen JTG, Gan I, van Goor AT, Bennebroek CA, van der Werf DJ, Ossewaarde-van Norel A, Mayland Nielsen CC, Tilanus M, van den Biesen PR, Schellekens PA, La Heij E, Faridpooya K, van Overdam K, Veckeneer M, van Meurs JC (2018) A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics. Acta Ophthalmol 96:348–355. https://doi.org/10.1111/aos.13610
Albrecht E, Richards JC, Pollock T, Cook C, Myers L (2011) Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial. Br J Ophthalmol 95:1385–1388. https://doi.org/10.1136/bjo.2010.187963
Moisseiev E, Abbassi S, Park SS (2017) Intravitreal dexamethasone in the management of acute endophthalmitis: a comparative retrospective study. Eur J Ophthalmol 27:67–73. https://doi.org/10.5301/ejo.5000866
Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, Mamalis N, Miller KM, Wykoff CC (2017) Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology 124:583–595. https://doi.org/10.1016/j.ophtha.2016.11.042
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the Saarland Medical Association (approval number 243/14) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Januschowski, K., Boden, K., Szurman, P. et al. Effectiveness of immediate vitrectomy and intravitreal antibiotics for post-injection endophthalmitis. Graefes Arch Clin Exp Ophthalmol 259, 1609–1615 (2021). https://doi.org/10.1007/s00417-021-05071-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05071-w